NDC 70518-0174-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0174
- Requested NDC
- 70518-0174-01
- Package NDCs from labels
- 70518-0174-0, 70518-0174-1, 70518-0174-2, 70518-0174-3, 70518-0174-4, 70518-0174-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-06-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USP | REMEDYREPACK INC. | 2026-06-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-0174-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 25 | |
| 70518-0174-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 | |
| 70518-0174-2 | Lisinopril and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 25 | |
| 70518-0174-3 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 25 | |
| 70518-0174-4 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-0174 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 21 | Current NDC, Legacy NDC, 5 package rows | 20250424_408e797a-2cf3-4ee6-9f9b-179a8cf3d799.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 8808879d-8c7e-45d1-8a49-c05d2cf845d3 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | ANDA077912 197886 E7199S1YWR 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 00f67e1a-6999-4295-9c9f-fcb1ce9711b8 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | ANDA077912 197887 E7199S1YWR 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | ec23c75d-68d5-46d0-be56-b96ddba19ed6 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | ANDA077912 197885 E7199S1YWR 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Glenmark Pharmaceuticals Inc., USA | 1e55800d-f77c-4950-a6d7-2055f4c7ea17 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan medoxomil, amlodipine and hydrochlorothiazide | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | 45e975ff-07b1-411a-96ee-a011d1619b1e | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | Northwind Health Company, LLC | 03fe066f-c3d7-fa71-e063-6294a90ac6f6 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f32ce8fe-6cbc-8a15-e053-2995a90a8eec | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2b749a6-17ff-e044-e053-2995a90aea28 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | c8c79657-a09a-bdb6-e053-2995a90ab673 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Northwind Health Company, LLC | ab2f8ab5-3c87-484a-e053-2995a90a42bb | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f835fa93-6529-c06d-e053-6394a90ad42a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Northwind Health Company, LLC | ae2cdf9b-e71e-8315-e053-2995a90a5310 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 3d801e51-e675-45eb-bc7e-407e610f4009 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 197886 E7199S1YWR 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Northwind Health Company, LLC | dac0c8f1-e3cf-11e6-e053-2a95a90adbcb | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 57a2f9bd-8ca5-437e-b911-5207f94cc6ba | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | ab8115a0-e96f-7aee-e053-2995a90a6ec0 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f3191ca2-4dbc-01f5-e053-2a95a90a572c | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | e3afa83d-c79c-848a-e053-2a95a90ac922 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Northwind Health Company, LLC | ae2d9df4-29ce-3d07-e053-2995a90ab184 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f32b8809-80e9-18f2-e053-2995a90a5428 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.